康西普治療公司
IT ˙ BIT ˙ US2183521028
€62.12 0.00 (0.00%)
2026-06-04
分享價格
SecurityIT:1CORT / Corcept Therapeutics Incorporated
InstitutionFmr Llc
Latest Disclosed Ownership3,190,192 shares
Latest Disclosed Value $ 128,596,647
Fmr Llc reports 32.12% increase in ownership of 1CORT / Corcept Therapeutics Incorporated

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 3,190,192 shares of Corcept Therapeutics Incorporated (IT:1CORT) valued at $107,956,097 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,414,640 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 32.12% during the quarter. The current value of the position is $198,174,727 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 3,190,192 775,552 32.12 128,597 53.04 0.0013
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,414,640 212,702 9.66 84,029 -54.08 0.0043
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,201,938 844,990 62.27 183,003 83.74 0.0095
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,356,948 -121,846 -8.24 99,600 -41.03 0.0056
2025-05-12 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,478,794 141,679 10.60 168,908 150.69 0.0108
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,337,115 -26,807 -1.97 67,377 6.74 0.0040
2024-11-13 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,363,922 269,074 24.58 63,122 77.45 0.0038
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,094,848 242,503 28.45 35,572 65.68 0.0023
2024-05-13 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 852,345 140,940 19.81 21,471 -7.08 0.0014
2024-02-13 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 711,405 27,481 4.02 23,106 24.01 0.0018
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 683,924 346,000 102.39 18,634 147.85 0.0016
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 337,924 199,755 144.57 7,519 151.27 0.0006
2023-08-11 2023-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 138,169 7,311 5.59 2,993 12.61 0.0003
2023-05-11 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 138,169 7,311 2,993 0.0003
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 130,858 -99,306 -43.15 2,658 -54.97 0.0003
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 230,164 169,899 281.92 5,901 311.79 0.0006
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 60,265 -251 -0.41 1,433 5.14 0.0001
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 60,516 52,727 676.94 1,363 779.35 0.0001
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 7,789 -45,032 -85.25 155 -85.08 0.0000
2022-02-14 2021-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 52,821 -190 -0.36 1,039 -10.97 0.0001
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 52,821 -190 1,039 0.0001
2021-08-13 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 53,011 192 0.36 1,167 -7.09 0.0001
2021-05-14 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 52,819 -44 -0.08 1,256 -9.18 0.0001
2021-02-08 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 52,863 -13,196 -19.98 1,383 20.26 0.0001
2020-11-13 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 66,059 -185,201 -73.71 1,150 -72.79 0.0001
2020-08-24 2020-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 251,260 -249,807 -49.86 4,226 -29.06 0.0005
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 251,260 -249,807 4,226 103.8205
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 501,067 -214,287 -29.96 5,957 -31.18 0.0008
2020-02-07 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 715,354 11,484 1.63 8,656 -13.00 0.0010
2019-11-13 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 703,870 0 0.00 9,949 26.77 0.0012
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 703,870 -60,925 -7.97 7,848 -12.60 0.0009
2019-05-13 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 764,795 203,200 36.18 8,979 19.67 0.0011
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 561,595 106,200 23.32 7,503 17.51 0.0010
2018-11-09 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 455,395 102,000 28.86 6,385 14.94 0.0007
2018-08-10 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 353,395 0 0.00 5,555 -4.44 0.0007
2018-05-14 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 353,395 0 0.00 5,813 -8.92 0.0007
2018-02-12 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 353,395 0 0.00 6,382 -6.44 0.0007
2017-11-13 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 353,395 0 0.00 6,821 63.57 0.0008
2017-08-29 2017-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 353,395 290,263 459.77 4,170 502.60 0.0005
2017-08-11 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 353,395 290,263 4,170
2017-05-11 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 63,132 63,132 692 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.